The experiments were done in mice, where temporarily reducing the activity of those brain immune cells led to a surprising gain of more than two hours of sleep per day. That result separates sleep recovery from the classic idea that removing amyloid plaques must come first. What matters for people is whether similar pathways operate in human brains and whether interventions can be safe, targeted, and lasting.
This line of research opens questions about who could benefit and how to translate findings from animals into human treatments that support cognition and quality of life. Follow the full article to see the methods researchers used and what steps are next for testing these ideas in people, because understanding the immune–sleep link may reshape approaches to keeping brains healthier for longer.
Scientists have uncovered an unexpected culprit behind sleep loss in Alzheimer’s disease: overactive immune cells in the brain. By temporarily removing these cells, researchers restored more than two hours of sleep per day in mice, revealing a promising new target for treatment.
